KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin

T. A. Wyatt, K. B. Pryzwansky, T. M. Lincoln

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

The effectiveness of the cGMP-dependent protein kinase inhibitor, KT5823, was investigated in human neutrophils. KT5823 did not inhibit the cGMP-dependent protein kinase mediated in vitro, or in situ phosphorylation of vimentin, a known substrate for this enzyme in activated neutrophils. In addition, KT5823 was shown to induce dramatic shape changes in neutrophils, suggesting it has an activating effect upon the cells.

Original languageEnglish (US)
Pages (from-to)3-14
Number of pages12
JournalResearch Communications in Chemical Pathology and Pharmacology
Volume74
Issue number1
StatePublished - Nov 7 1991

Fingerprint

Cyclic GMP-Dependent Protein Kinases
Phosphorylation
Vimentin
Neutrophils
Protein Kinase Inhibitors
Substrates
Enzymes
KT 5823

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Toxicology
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin. / Wyatt, T. A.; Pryzwansky, K. B.; Lincoln, T. M.

In: Research Communications in Chemical Pathology and Pharmacology, Vol. 74, No. 1, 07.11.1991, p. 3-14.

Research output: Contribution to journalArticle

@article{02112749c61d45efa89afafa1b9a7830,
title = "KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin",
abstract = "The effectiveness of the cGMP-dependent protein kinase inhibitor, KT5823, was investigated in human neutrophils. KT5823 did not inhibit the cGMP-dependent protein kinase mediated in vitro, or in situ phosphorylation of vimentin, a known substrate for this enzyme in activated neutrophils. In addition, KT5823 was shown to induce dramatic shape changes in neutrophils, suggesting it has an activating effect upon the cells.",
author = "Wyatt, {T. A.} and Pryzwansky, {K. B.} and Lincoln, {T. M.}",
year = "1991",
month = "11",
day = "7",
language = "English (US)",
volume = "74",
pages = "3--14",
journal = "Research Communications in Chemical Pathology and Pharmacology",
issn = "0034-5164",
publisher = "PJD Publications Ltd",
number = "1",

}

TY - JOUR

T1 - KT5823 activates human neutrophils and fails to inhibit cGMP-dependent protein kinase phosphorylation of vimentin

AU - Wyatt, T. A.

AU - Pryzwansky, K. B.

AU - Lincoln, T. M.

PY - 1991/11/7

Y1 - 1991/11/7

N2 - The effectiveness of the cGMP-dependent protein kinase inhibitor, KT5823, was investigated in human neutrophils. KT5823 did not inhibit the cGMP-dependent protein kinase mediated in vitro, or in situ phosphorylation of vimentin, a known substrate for this enzyme in activated neutrophils. In addition, KT5823 was shown to induce dramatic shape changes in neutrophils, suggesting it has an activating effect upon the cells.

AB - The effectiveness of the cGMP-dependent protein kinase inhibitor, KT5823, was investigated in human neutrophils. KT5823 did not inhibit the cGMP-dependent protein kinase mediated in vitro, or in situ phosphorylation of vimentin, a known substrate for this enzyme in activated neutrophils. In addition, KT5823 was shown to induce dramatic shape changes in neutrophils, suggesting it has an activating effect upon the cells.

UR - http://www.scopus.com/inward/record.url?scp=0025954537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025954537&partnerID=8YFLogxK

M3 - Article

C2 - 1666198

AN - SCOPUS:0025954537

VL - 74

SP - 3

EP - 14

JO - Research Communications in Chemical Pathology and Pharmacology

JF - Research Communications in Chemical Pathology and Pharmacology

SN - 0034-5164

IS - 1

ER -